Published December 2018 | Version v1
Journal article

YAP via interacting with STAT3 regulates VEGF-induced angiogenesis in human retinal microvascular endothelial cells

  • 1. Department of Ophthalmology, Lixiang Eye Hospital of Soochow University, Suzhou, Jiangsu (China)
  • 2. Department of Pathogen Biology, Medical College, Nantong University, Nantong, Jiangsu (China)
  • 3. Department of Ophthalmology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu (China)

Description

Endothelial dysfunction is a main feature of retinal neovascular diseases which are the leading cause of blindness in developed countries. Yes-associated protein (YAP) and signal transducer and activator of transcription factor 3 (STAT3) participate in angiogenesis via vascular endothelial growth factor (VEGF) signaling. Additionally, YAP can bind STAT3 in endothelial cells. In the study, dimethyloxalylglycine (DMOG) stimulated human retinal microvascular endothelial cells (HRMECs) was used as retinal endothelial hypoxia model. The proliferation of HRMECs, as well as t-YAP, p-STAT3 (Tyr705) increased, while p-YAP (Ser127), p-YAP (Ser397) decreased following hypoxia. Meanwhile, YAP and STAT3 translocated to the nucleus. YAP knockdown inhibited the proliferation, migration and tube formation of HRMECs. YAP overexpression up-regulated phosphorylation of STAT3. The YAP overexpression-induced HRMECs proliferation, migration and tube formation were reversed by S3I-201, a selective STAT3 inhibitor. YAP interacted with STAT3 to promote STAT3 nuclear translocation. Additionally, YAP and STAT3 promoted the transcription of VEGF synergistically. Finally, inhibition of YAP alleviated retinal pathological neovascularization in mouse oxygen-induced retinopathy (OIR) model. In summary, activated YAP interacted with STAT3 to promote the activation and nuclear translocation of STAT3, hence boosted the proliferation, migration and tube formation of HRMECs via VEGF signaling following hypoxia. The data will further elucidate the mechanisms of retinal neovascular diseases.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.yexcr.2018.10.007

Additional details

Identifiers

DOI
10.1016/j.yexcr.2018.10.007;
PII
S0014482718306967;

Publishing Information

Journal Title
Experimental Cell Research
Journal Volume
373
Journal Issue
1-2
Journal Page Range
p. 155-163
ISSN
0014-4827
CODEN
ECREAL

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
52123084
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ANGIOGENESIS; ANOXIA; GROWTH FACTORS
Descriptors DEC
MITOGENS; ORGANIC COMPOUNDS; PROTEINS

Optional Information

Copyright
Copyright (c) 2018 Elsevier Inc. All rights reserved.